MOS
Proto-oncogene serine/threonine-protein kinase mos
Also known as: MOS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P00540
- Gene
- MOS
- Ensembl
- ENSG00000172680
- Chromosome
- 8
- Canonical length
- 346 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
MOS is a serine/threonine kinase that activates the MAP kinase cascade through direct phosphorylation of the MAP kinase activator MEK (MAP2K1; MIM 176872) (Prasad et al., 2008 [PubMed 18246541]).[supplied by OMIM, Jul 2009]
Canonical amino-acid sequenceUniProt
346 residues, UniProt reviewed canonical sequence.
>P00540|MOS
1 MPSPLALRPY LRSEFSPSVD ARPCSSPSEL PAKLLLGATL PRAPRLPRRL AWCSIDWEQV
61 CLLQRLGAGG FGSVYKATYR GVPVAIKQVN KCTKNRLASR RSFWAELNVA RLRHDNIVRV
121 VAASTRTPAG SNSLGTIIME FGGNVTLHQV IYGAAGHPEG DAGEPHCRTG GQLSLGKCLK
181 YSLDVVNGLL FLHSQSIVHL DLKPANILIS EQDVCKISDF GCSEKLEDLL CFQTPSYPLG
241 GTYTHRAPEL LKGEGVTPKA DIYSFAITLW QMTTKQAPYS GERQHILYAV VAYDLRPSLS
301 AAVFEDSLPG QRLGDVIQRC WRPSAAQRPS ARLLLVDLTS LKAELGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MOS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 0.7 nTPM
Expression across tissuesHPA
Tissue
- testis: 0.7 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- late primary spermatocytes: 9.9 nCPM
- early spermatids: 6.4 nCPM
- oocytes: 4.6 nCPM
- microglia: 1.9 nCPM
- late spermatids: 0.5 nCPM
- sertoli cells: 0.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- amygdala: 0.3 nTPM
- hippocampal formation: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- medulla oblongata: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MOS.
Disease | AllUniProt
Conditions MOS is implicated in, by any mechanism.
- Oocyte/zygote/embryo maturation arrest 20 (OZEMA20) MIM:620383
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 60 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Oocyte/zygote/embryo maturation arrest 20
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.59
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- establishment of meiotic spindle orientation
- MAPK cascade
- meiotic spindle organization
- oocyte maturation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of MAPK cascade
- regulation of meiotic nuclear division
- signal transduction
- negative regulation of metaphase/anaphase transition of meiotic cell cycle
Molecular functions
- ATP binding
- MAP kinase kinase kinase activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MOS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MOS as an antibody target. Whether an autoantibody or antibody against MOS could matter depends on whether native MOS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MOS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MOS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...